SHCM
ABBV icon

Stokes & Hubbell Capital Management’s AbbVie ABBV Stock Holding History

Stokes & Hubbell Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$3.48M Buy
43,114
+2,461
+6% +$201K 0.73% 42
2018
Q4 		$3.75M Buy
40,653
+72
+0.2% +$6.33K 0.85% 31
2018
Q3 		$3.84M Sell
40,581
-375
-0.9% -$35.6K 0.8% 36
2018
Q2 		$3.79M Buy
40,956
+364
+0.9% +$35.5K 0.86% 33
2018
Q1 		$3.84M Sell
40,592
-9,771
-19% -$1.07M 0.89% 32
2017
Q4 		$4.87M Sell
50,363
-98
-0.2% -$9.24K 1.17% 20
2017
Q3 		$4.48M Buy
50,461
+418
+0.8% +$31.8K 1.16% 20
2017
Q2 		$3.63M Buy
50,043
+5,759
+13% +$387K 1.12% 26
2017
Q1 		$2.89M Buy
44,284
+8,503
+24% +$535K 0.98% 29
2016
Q4 		$2.24M Buy
35,781
+893
+3% +$54.5K 0.87% 33
2016
Q3 		$2.2M Buy
34,888
+127
+0.4% +$8.22K 0.91% 27
2016
Q2 		$2.15M Sell
34,761
-92
-0.3% -$5.61K 0.93% 28
2016
Q1 		$1.99M Buy
34,853
+742
+2% +$41.4K 0.92% 29
2015
Q4 		$2.02M Sell
34,111
-119
-0.3% -$6.85K 1.1% 25
2015
Q3 		$1.86M Buy
+34,230
New +$2.23M 1.13% 20

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Stokes & Hubbell Capital Management's ABBV Position: Q1 2019 in Review

Stokes & Hubbell Capital Management increased its AbbVie (ABBV) stake by 6.1% in Q1 2019, buying an estimated $201K and bringing the position to 43,114 shares worth $3.48M. The position accounts for 0.73% of the portfolio, ranked #42.

Stokes & Hubbell Capital Management first reported a position in ABBV in Q3 2015 and has held it in 15 quarters since. The position peaked at $4.87M in Q4 2017. 2,034 funds tracked by Wall St. Rank hold ABBV as of Q1 2019.

  • Stokes & Hubbell Capital Management held 43,114 shares of AbbVie worth $3.48M as of Q1 2019.
  • Stokes & Hubbell Capital Management bought 2,461 AbbVie shares in Q1 2019, an estimated $201K.
  • AbbVie made up 0.73% of Stokes & Hubbell Capital Management's portfolio in Q1 2019, its #42 holding.
  • Stokes & Hubbell Capital Management first reported a position in AbbVie in Q3 2015 and has held it in 15 quarters since.
  • Stokes & Hubbell Capital Management's AbbVie position peaked at $4.87M in Q4 2017.
  • 2,034 funds tracked by Wall St. Rank held AbbVie as of Q1 2019.

Based on Stokes & Hubbell Capital Management's 13F filing for Q1 2019, filed 24 Apr 2019.